Insider · CIK 0001827232
Arundathy N. Pandite
Files at STTK (Shattuck Labs, Inc.). First filing May 14, 2026, latest Jul 2, 2026.
In brief
Arundathy N. Pandite files SEC Form 4 as officer at STTK (Shattuck Labs, Inc.). Since May 14, 2026, Arundathy N. Pandite has reported 0 open-market buys worth $0 and 2 open-market sells worth $409k, the latest filed on Jul 2, 2026.
A track record needs three past buys with six months of prices behind them; Arundathy N. Pandite has 0, so none is measured yet.
The newest scored trade: sold $210k of STTK on Jun 30, 2026, filed Jul 2, 2026, scored 20 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $409k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STTK: Shattuck Labs, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Shattuck Labs, Inc. | $210k 30,000 shares | -18% | +848% from low-12% from high | |
| 20Weak | Shattuck Labs, Inc. | $198k 30,000 shares | -15% | +804% from low-16% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 12, 2026 | STTK Shattuck Labs, Inc. | 60,000 0.08% of outstanding | $421k | May 12, 2026 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | STTK Shattuck Labs, Inc. | SOpen-market sale Common Stock10b5-1 | -30,000 | $7.01 | $210k | 136,219 | Jul 2, 2026 |
| May 12, 2026 | STTK Shattuck Labs, Inc. | SOpen-market sale Common Stock10b5-1 | -30,000 | $6.61 | $198k | 166,219 | May 14, 2026 |
| Jan 25, 2026 | STTK Shattuck Labs, Inc. | FTax withholding Common Stock | -3,195 | $4.15 | $13k | 196,219 | Jan 27, 2026 |
| Jan 10, 2026 | STTK Shattuck Labs, Inc. | FTax withholding Common Stock | -6,851 | $4.75 | $33k | 199,414 | Jan 13, 2026 |
| Jan 10, 2026 | STTK Shattuck Labs, Inc. | AGrant or award Common Stockderivative | +487,800 | $0.00 | $0 | 487,800 | Jan 13, 2026 |
Questions about Arundathy N. Pandite
Answered from the filings on this page, as of the latest one.
Is Arundathy N. Pandite buying or selling?
In the last 12 months Arundathy N. Pandite reported 0 open-market buys worth $0 and 2 open-market sells worth $409k on SEC Form 4; the latest was sold $210k of STTK on Jun 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Arundathy N. Pandite's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arundathy N. Pandite has 0.
Where does Arundathy N. Pandite file Form 4?
Arundathy N. Pandite has filed Form 4 at STTK (Shattuck Labs, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.